Test Price
2,800 AED✅ Home Collection Available
MICU1 Gene Myopathy with Extrapyramidal Signs Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MICU1 للاعتلال العضلي مع علامات خارج السبيل الهرمي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing. Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy. Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation. Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الفحص الجيني لمستوى عالٍ من الدقة لتحديد الطفرات في جين MICU1 المرتبط بالاعتلال العضلي الوراثي النادر المصحوب بعلامات خارج السبيل الهرمي، باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS) بحساسية تشخيصية تصل إلى 99.9%، ويشمل استشارة وراثية متكاملة وسحب عينات منزلي معتمد.
Overview
This advanced NGS test thoroughly screens the entire coding region of the MICU1 gene to identify pathogenic variants responsible for an ultra-rare mitochondrial disorder causing proximal muscle weakness and diverse extrapyramidal signs such as dystonia or parkinsonism. Delivered through our ISO-certified genomics lab, the result empowers precise diagnosis, family screening, and personalized management within 3–4 weeks.
فحص جيني شامل يحلل كامل المنطقة المشفرة لجين MICU1 للكشف عن الطفرات المسببة لاضطراب الميتوكوندريا النادر الذي يضعف العضلات ويُحدث علامات حركية لا إرادية، ما يوفر تشخيصاً دقيقاً خلال 3–4 أسابيع.
| Feature | Our Test (Precision Genomics) | Closest Alternative (Standard Panel) |
|---|---|---|
| Precision | Full gene NGS with complete MICU1 coverage, pathogenic variant detection >99.9% | Targeted sequencing of selected exons only, may miss rare intronic variants |
| Methodology | Illumina NovaSeq X Plus, bioinformatics aligned with ACMG 2026 guidelines | Older capillary sequencing or limited gene panels, updated less frequently |
| Speed | 3–4 weeks from sample receipt | 6–8 weeks typical |
Pre‑Test Requirements
- Mandatory genetic counselling session to draw a pedigree chart of affected family members and discuss implications.
- Provide clinical history of neurological symptoms and prior investigations.
- No fasting or medication adjustments are necessary; inform your doctor about any anticoagulant therapy for blood draw.
Physician Insight & Safety Protocol
“As a senior neurologist deeply involved in neurogenetics, I understand the emotional and clinical complexity of pursuing a genetic diagnosis for your condition. This test is a powerful tool to confirm MICU1‑related myopathy, but results must be interpreted alongside your full clinical picture and family pedigree. I urge you not to make any treatment changes without direct consultation with your specialist.”
— Dr. PRABHAKAR REDDY (DHA License: 61713011)
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & Emergency Red Flags
- Do not proceed if you are not under the direct supervision of a neurologist or clinical geneticist for suspected MICU1‑related disease.
- This test is not a screening tool for asymptomatic individuals without a relevant family history.
- If you are pregnant, or have a bleeding disorder, inform your genetic counsellor before sample collection.
- ER Red Flag: Seek immediate medical attention if you experience sudden worsening of muscle weakness, breathing difficulty, or severe movement disturbances while awaiting your results.
Patient FAQ & Clinical Guidance
1. What exactly does the MICU1 gene test detect, and how does that explain my symptoms?
MICU1 mutations disrupt mitochondrial calcium uptake, leading to energy failure in muscles and basal ganglia. The test identifies pathogenic variants in the MICU1 gene that cause a progressive myopathy with involuntary movements (extrapyramidal signs) such as dystonia, rigidity, or tremor. A positive result confirms the genetic diagnosis, allowing targeted physiotherapy, mitochondrial support, and family cascade testing.
2. لماذا أشترط جلسة استشارة وراثية قبل إجراء هذا الفحص؟
جين MICU1 مسؤول عن تنظيم الكالسيوم الميتوكوندري؛ وطفراته تؤدي إلى اعتلال عضلي وعلامات خارج هرمية. جلسة الاستشارة الوراثية ضرورية لرسم شجرة العائلة وتحديد نمط الوراثة، مما يضمن تفسير النتيجة بدقة وتقديم التوصيات الطبية المناسبة لك ولأفراد العائلة الآخرين.
3. Can a negative result rule out my condition completely?
A negative NGS test still leaves other genetic or acquired myopathies as possible causes for your symptoms. Because this focuses solely on MICU1, a normal report does not exclude other neuromuscular or mitochondrial disorders. Your neurologist will integrate the result with electromyography, muscle MRI, and additional genetic panels if clinically indicated.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians